剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

07666 剂泰科技-P

已收盘 09-29 16:08:04

15.990

+0.090

+0.57%

最高16.370	最低15.710	成交量469.10万
今开16.100	昨收15.900	日振幅4.15%
总市值189.16亿	流通市值173.17亿	总股本11.83亿
成交额7,514万	换手率0.43%	流通股本10.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"剂泰科技-P","latestPrice":15.99,"timestamp":1790669284007,"preClose":15.9,"halted":0,"volume":4691000,"delay":0,"changeRate":0.005660377358490557,"floatShares":1083000000,"shares":1183000000,"eps":-0.5450155870796656,"marketStatus":"已收盘","change":0.09,"latestTime":"09-29 16:08:04","open":16.1,"high":16.37,"low":15.71,"amount":75135365,"amplitude":0.041509,"askPrice":16,"askSize":18000,"bidPrice":15.99,"bidSize":9500,"shortable":3,"etf":0,"ttmEps":-0.4025208617740746,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790731800000},"marketStatusCode":5,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":15.9,"openAndCloseTimeList":[[1790645400000,1790654400000],[1790658000000,1790668800000]],"volumeRatio":0.687434,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/07666","defaultTab":"news","newsList":[{"id":"1141526751","title":"剂泰科技-P2026年中期营收1.54亿元，经调整后净亏损0.51亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141526751","media":"公告速递","labels":["SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141526751?lang=zh_cn&edition=full","pubTime":"2026-09-29 17:23","pubTimestamp":1790673787,"startTime":"0","endTime":"0","summary":"根据公司最新披露的2026年中期报告，剂泰科技-P于报告期内实现来自客户合约的收入约1.54亿元，同比上年同期大幅增长13,399%。本期经调整后净亏损约0.51亿元，相比上年同期的1.17亿元收窄56.4%。报告期内经营活动产生的现金流出净额约1.62亿元，而上年同期为约0.96亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"剂泰科技-P2026年中期营收1.54亿元，经调整后净亏损0.51亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120179535","title":"异动解读｜剂泰科技-P盘中下跌6.21%，报16.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120179535","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120179535?lang=zh_cn&edition=full","pubTime":"2026-09-24 10:13","pubTimestamp":1790216028,"startTime":"0","endTime":"0","summary":"9月24日，剂泰科技-P盘中下跌6.21%，报16.3港元/股，成交额3716.49万港元。剂泰科技-P所在的生物科技行业中，个股普遍承压，康方生物跌3.69%，信达生物跌3.63%，百济神州跌1.47%，荣昌生物跌5.77%，三生制药跌3.76%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669743721","title":"港股异动 | 剂泰科技-P(07666)再涨超6% 跨赛道巨头布局AI4S制药 NanoForge商业化成果迎集中释放期","url":"https://stock-news.laohu8.com/highlight/detail?id=2669743721","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669743721?lang=zh_cn&edition=full","pubTime":"2026-09-23 11:15","pubTimestamp":1790133344,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P再涨超6%，截至发稿，涨5.01%，报17.62港元，成交额7242.99万港元。东吴证券指出，全球科技巨头正在以不同路径深度嵌入生物医药，AI制药进入战略入局阶段。值得一提的是，上半年，剂泰科技NanoForge商业化成果进入集中释放期，期内营收超过1.54亿元，超过去年全年收入47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","07666","BK1574","BK1191","VXUS","BK4588","BK1161","BK4585","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669174377","title":"港股异动 | 剂泰科技-P(07666.HK)再涨超6% 跨赛道巨头布局AI4S制药 NanoForge商业化成果迎集中释放期","url":"https://stock-news.laohu8.com/highlight/detail?id=2669174377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669174377?lang=zh_cn&edition=full","pubTime":"2026-09-23 11:15","pubTimestamp":1790133344,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1574","BK1191","07666","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125690103","title":"异动解读｜剂泰科技-P盘中上涨6.85%，CEO演讲强调Biological AI数据壁垒叠加十五五规划持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1125690103","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125690103?lang=zh_cn&edition=full","pubTime":"2026-09-23 10:43","pubTimestamp":1790131407,"startTime":"0","endTime":"0","summary":"9月23日，剂泰科技-P盘中上涨6.85%，报17.93港元，成交额5873.57万港元。消息面上，多重利好持续催化。公司联合创始人、CEO赖才达近日受邀发表主旨演讲，强调生物医药AI核心竞争力在于持续获取高质量实验数据并转化为模型能力，提出AI制药\"三层蛋糕\"技术架构。政策端，\"十五五\"规划将AI制药列入医药工业重点任务，明确培育高价值应用场景。业务端，公司此前与昭衍生物签署合资协议设立昭泰智药，打造mRNA药物研发与产业化平台。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技盘中上涨，AI制药利好催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669118104","title":"剂泰科技-P盘中涨超7% Biological AI的核心竞争力为真实实验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2669118104","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669118104?lang=zh_cn&edition=full","pubTime":"2026-09-22 11:55","pubTimestamp":1790049300,"startTime":"0","endTime":"0","summary":"模拟交易客户端剂泰科技-P盘中涨超7%。截至发稿，股价上涨3.85%，现报17.53港元，成交额8172.92万港元。剂泰科技联合创始人、董事长兼CEO赖才达受邀作《可编程生物学的时代：AI的新前沿》主旨演讲。相比“模型有多大”，赖才达博士更强调另一件事：生物医药AI最终拼的是能否持续获得高质量实验数据，并把这些数据转化成模型能力。据悉，赖才达用一个“三层蛋糕”来描述AI制药的技术架构。最底层也是最厚的第一层，是干实验与湿实验数据平台。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-22/doc-inissitf7081721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","07666","VTHR","QTOC","AIPO","AGIX","ARTY","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669190993","title":"港股异动 | 剂泰科技-P(07666.HK)早盘涨近7% Biological AI的核心竞争力为真实实验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2669190993","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669190993?lang=zh_cn&edition=full","pubTime":"2026-09-22 10:58","pubTimestamp":1790045932,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160689123","title":"异动解读｜剂泰科技-P盘中上涨5.15%，十五五规划与mRNA合资平台等多重利好持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1160689123","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160689123?lang=zh_cn&edition=full","pubTime":"2026-09-22 10:23","pubTimestamp":1790043794,"startTime":"0","endTime":"0","summary":"9月22日，剂泰科技-P盘中上涨5.15%，报17.75港元，成交额3881.89万港元，近期累计涨幅显著。消息面上，多重利好持续发酵。政策端，\"十五五\"规划将AI制药列入医药工业重点任务，明确提出\"AI制药高价值应用场景培育\"；业务端，公司近日与昭衍生物签署合资协议设立昭泰智药，打造mRNA药物创新研发与产业化制造平台，NanoForge平台已实现对人体内8个关键器官与组织的靶向递送。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技盘中上涨，AI制药多重利好催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669813957","title":"港股异动 | 剂泰科技-P(07666)再涨超9% 多重共振带动AI制药上行 公司AI+递送平台价值逐步显现","url":"https://stock-news.laohu8.com/highlight/detail?id=2669813957","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669813957?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:06","pubTimestamp":1789956363,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P再涨超9%，近三个交易日累涨超35%。这份纲领性文件将AI制药列入医药工业五年计划的重点任务，明确提出“深化人工智能赋能升级”，并专门列出“AI制药高价值应用场景培育”专栏。当前，AI制药正处于行业外新增资本与产业内研发预算双轮驱动的上行通道。行业内，礼来等MNC持续扩大AI在药物发现、临床前及研发流程中的应用；Anthropic则设立生物实验室，推进AI药物研发项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498528.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","KCAI","BK4588","ARTY","01477","BK1161","BK1191","CHAT","QTOC","VXUS","AIPO","07666","VTHR","BK1574","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103868237","title":"异动解读｜剂泰科技-P盘中上涨5.52%，十五五规划落地叠加mRNA合资平台消息持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1103868237","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103868237?lang=zh_cn&edition=full","pubTime":"2026-09-21 09:35","pubTimestamp":1789954500,"startTime":"0","endTime":"0","summary":"9月21日，剂泰科技-P盘中上涨5.52%，报18.0港元，成交额3296.7万港元。消息面上，多重利好持续发酵。政策端，\"十五五\"规划重磅落地，AI医疗概念股集体走强，剂泰科技上一交易日曾涨超14%领涨板块。根据协议，剂泰科技在上游提供AI驱动的mRNA序列设计与纳米递送能力，NanoForge平台已实现对人体内8个关键器官与组织的靶向递送。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技盘中上涨，AI医疗与mRNA平台双催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668957971","title":"Tempus大涨之后，德适科技(02526)的AI4S价值正在被重新发现","url":"https://stock-news.laohu8.com/highlight/detail?id=2668957971","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668957971?lang=zh_cn&edition=full","pubTime":"2026-09-19 09:12","pubTimestamp":1789780357,"startTime":"0","endTime":"0","summary":"同日德适收涨0.39%。Tempus的经营数据给出了线索。沿着这条线研究德适，可以看到一家更接近AI4S本质的公司。iMedLoop于7月上线，晚于上半年报告期。德适正在构建AI4S看重的“发现问题—组织数据—训练模型—验证效果—重新交付”闭环。Tempus的行情提醒市场，高质量医学数据进入真实工作流并产生商业回报，才更有基础获得更高定价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1161","03696","BK1100","07666","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668191239","title":"港股午评|恒生指数早盘涨0.67%     AI制药板块大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2668191239","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668191239?lang=zh_cn&edition=full","pubTime":"2026-09-18 12:00","pubTimestamp":1789704004,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数涨0.67%，涨164点，报24768点；恒生科技指数涨1.74%。港股早盘成交1070亿港元。十部门印发医药十五五规划，机构看好医药迎“Claude”时刻。AI制药进入战略入局阶段。曦智科技-P涨超17%。天数智芯涨超13%，公司有望持续受益AI资本开支的增长及算力自主可控浪潮。MINIMAX-W涨13%，旗下多款产品通过Singtel AI Pass纳入配套订阅计划。俊知集团涨超10%，收购青海中利光纤技术有望打开AI算力相关光纤产品增量空间。大股东解禁期满。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03423","HSI","LU0572939691.SGD","LU1235295612.USD","BK1617","LNVGY","09115","LU1366334578.USD","03088","HK0000320223.HKD","LU0310800965.SGD","01879","603127","BK1141","BK1163","LU0128525689.USD","LU0128522157.USD","LU2242644610.SGD","07500","300077","BK1149","LU0264606111.USD","LU0972618739.USD","LU0326950275.SGD","LU0052756011.USD","HK0000306701.USD","HK0000320264.USD","LU0672654166.SGD","83115","LU1366334651.USD","00992","LU0181495838.USD","03419","BK1544","07226","BK1526","LU0348825331.USD","02837","LU1188198961.HKD","BK1198","82800","07666","07300","BK1576","BK1607","03033","MCHmain","LU0791590937.USD","BK1161","LU0828237940.HKD","09088","HHImain","LU0543330483.HKD","06658","07552","IE0003895053.USD","LU0862451753.SGD","LU0791591158.USD","HK0000306685.HKD","LU0463099449.HKD","07630","02670","09067","LU1808992512.USD","06127","IE0032431581.USD","BK1506","02701","LU1831875114.USD","BK1193","07200","LU0049112450.USD","600547","LU1267930227.SGD","LU0561508036.HKD","03417","02228","02833","LU0029875118.USD","513600","03037","BK1237","IE0034224299.USD","LU0572940350.SGD","03067","BK1592","02656","LU0890818403.SGD","01300","LU0348827113.USD","02142","80992","01818","LU1046422090.SGD","01787","02800","LU0370786039.SGD","03696","BK1117","BK1183","BK1583","LU0244354667.USD","03115","HSTECH","LU0140636845.USD","03032","TCHI","LU0320764755.SGD","LU0862451837.USD","09903","00100","BK1197","BK1574","IE00B0JY6N72.USD","LU0048580855.USD","LU0417516902.SGD","LU1785774172.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668891996","title":"AI制药概念股早盘集体走高 剂泰科技-P涨逾13%英硅智能涨逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668891996","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668891996?lang=zh_cn&edition=full","pubTime":"2026-09-18 10:11","pubTimestamp":1789697460,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端AI制药概念股早盘集体走高，截至发稿，剂泰科技-P（07666）上涨13.20%，报17.58港元；英硅智能（03696）上涨10.98%，报59.65港元；晶泰控股（02228）上涨8.34%，报7.47港元；金斯瑞生物科技（01548）上涨6.39%，报39.60港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-18/doc-inisfazi3502899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIPO","QTOC","BK1161","BK1574","VTHR","01477","AGIX","CHAT","ARTY","07666","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668919445","title":"港股异动 | 生物医药股悉数走高 十部门印发医药十五五规划 机构看好医药迎“Claude”时刻","url":"https://stock-news.laohu8.com/highlight/detail?id=2668919445","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668919445?lang=zh_cn&edition=full","pubTime":"2026-09-18 10:04","pubTimestamp":1789697085,"startTime":"0","endTime":"0","summary":"消息面上，工信部等十部门联合发布《医药工业发展\"十五五\"规划》，提出到2030年的发展目标：生物医药研发应用稳居世界前列，创新驱动效能充分释放，重点领域关键核心技术实现系统性突破，生物医药产业加速成为国家新兴支柱产业。浙商证券表示，高频迭代短期将会带来验证阶段需求的井喷，但长期来看，高速迭代可能会带来平台能力的提升和泛化，能够持续迭代的发现平台能力提升或是行业的核心，医药行业的Claude也许将要到来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497761.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","VXUS","BK1583","BK1515","01672","07666","09688","BK1141","BK1574","06127","BK4581","159938","BK4585","399441","XBI","BK4588","BK1576","09939","KCAI","02142","161726","LU2488822045.USD","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668291615","title":"港股异动 | AI制药进入战略入局阶段 剂泰科技-P(07666.HK)涨超11%领涨板块 英硅智能(03696.HK)涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668291615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668291615?lang=zh_cn&edition=full","pubTime":"2026-09-18 09:36","pubTimestamp":1789695405,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","BK1161","BK1574","BK1191","03696","07666","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194789363","title":"异动解读｜剂泰科技-P盘中上涨8.56%，携手昭衍生物打造mRNA药物研发平台消息持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1194789363","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194789363?lang=zh_cn&edition=full","pubTime":"2026-09-18 09:33","pubTimestamp":1789695237,"startTime":"0","endTime":"0","summary":"9月18日，剂泰科技-P盘中上涨8.56%，报17.1港元，成交额2961.84万港元。消息面上，公司近日与昭衍生物正式签署合资协议，共同设立合资公司昭泰智药，携手打造mRNA药物创新研发与产业化制造平台，首个合作项目已启动。根据协议，剂泰科技将在上游提供设计与递送能力，NanoForge已实现对人体内8个关键器官与组织的靶向递送。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技携手昭衍生物，共建mRNA药物平台","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668580019","title":"剂泰科技-P午前涨逾14% 携手昭衍新药打造mRNA药物创新研发与产业化制造平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2668580019","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668580019?lang=zh_cn&edition=full","pubTime":"2026-09-17 11:28","pubTimestamp":1789615680,"startTime":"0","endTime":"0","summary":"模拟交易客户端剂泰科技-P盘中涨超16%，截至发稿，股价上涨13.79%，现报15.68港元，成交额1.53亿港元。近日，据剂泰科技官微消息，公司与昭衍生物正式签署合资协议，共同设立合资公司昭泰智药，携手打造mRNA药物创新研发与产业化制造平台。根据协议，剂泰科技将在上游提供设计与递送能力，NanoForge已实现对人体内8个关键器官与组织的靶向递送。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-17/doc-inisayan9411675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1141","603127","BK1576","06127","07666","BK1161","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668930643","title":"港股异动 | 剂泰科技-P(07666.HK)盘中涨超11% 携手昭衍新药打造mRNA药物创新研发与产业化制造平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2668930643","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668930643?lang=zh_cn&edition=full","pubTime":"2026-09-17 10:06","pubTimestamp":1789610811,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06127","07666","BK1576","BK1141","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177424167","title":"异动解读｜剂泰科技-P盘中上涨5.08%，入通后连续大幅回调后再迎技术性反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1177424167","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177424167?lang=zh_cn&edition=full","pubTime":"2026-09-17 09:45","pubTimestamp":1789609514,"startTime":"0","endTime":"0","summary":"9月17日，剂泰科技-P盘中上涨5.08%，报14.48港元，成交额2185.41万港元。消息面上，公司自9月7日正式调入港股通标的以来，短线累计涨幅曾超四成，但自9月10日起获利盘集中出逃，连续多日遭遇回调，9月16日更单日大跌7.65%收报14.00港元。经过持续深度回吐，短线抛压有所释放，今日股价出现技术性反弹。基本面方面，公司上半年营业收入达1.54亿元，同比大增逾133倍，经调整净亏损收窄56.4%；自研AiTEM平台已落地恒瑞医药，NanoForge商业化持续推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技盘中上涨，入通后技术性反弹","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118885599","title":"异动解读｜剂泰科技-P盘中上涨5.54%，入通后连续回调多日迎来技术性反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1118885599","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118885599?lang=zh_cn&edition=full","pubTime":"2026-09-15 09:49","pubTimestamp":1789436999,"startTime":"0","endTime":"0","summary":"9月15日，剂泰科技-P盘中上涨5.54%，报16.0港元，成交额2923.88万港元。消息面上，公司自9月7日正式调入港股通标的以来，短线累计涨幅曾超四成，但自9月10日起因获利盘积聚连续多日遭遇回调，9月11日及9月14日分别下跌逾5%。经过持续回吐后，短线抛压有所释放，今日股价出现反弹。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"剂泰科技入通后回调充分，今日迎来技术性反弹","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.metistechbio.com","stockEarnings":[{"period":"1week","weight":-0.0581},{"period":"1month","weight":0.1455},{"period":"3month","weight":0.0352},{"period":"6month","weight":0.5143},{"period":"ytd","weight":0.5143}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0368},{"period":"3month","weight":0.077},{"period":"6month","weight":-0.0258},{"period":"1year","weight":-0.0569},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"剂泰科技（北京）股份有限公司是一家主要从事人工智能（AI）纳米材料创新的中国公司。NanoForge是该公司的人工智能驱动纳米科技创新体系的基础，涵盖脂质库、人工智能基础模型、METiS AI智能体、量子化学与分子动力学模拟及人工智能驱动的筛选平台。该公司开发了三大专业的解决方案，包括AiTEM、AiLNP及AiRNA平台，用以模拟、预测及阐释纳米级别的相互作用关系，从而实现对先进纳米材料及其相关有效载荷的合理设计、优化及验证。","exchange":"SEHK","name":"剂泰科技-P","nameEN":"METIS TECHBIO-P"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"剂泰科技-P,07666,剂泰科技-P股票,剂泰科技-P股票老虎,剂泰科技-P股票老虎国际,剂泰科技-P行情,剂泰科技-P股票行情,剂泰科技-P股价,剂泰科技-P股市,剂泰科技-P股票价格,剂泰科技-P股票交易,剂泰科技-P股票购买,剂泰科技-P股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}